MENU
+Compare
MRUS
Stock ticker: NASDAQ
AS OF
Jun 30, 04:59 PM (EDT)
Price
$52.56
Change
-$0.37 (-0.70%)
Capitalization
3.95B

MRUS Merus NV Forecast, Technical & Fundamental Analysis

Merus NV is a clinical-stage immuno-oncology company... Show more

Industry: #Biotechnology
MRUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for MRUS with price predictions
Jun 27, 2025

MRUS sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for MRUS moved above the 200-day moving average on June 17, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 64 cases where MRUS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The 10-day moving average for MRUS crossed bullishly above the 50-day moving average on May 27, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 233 cases where MRUS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for MRUS moved out of overbought territory on June 04, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 similar instances where the indicator moved out of overbought territory. In of the 32 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on June 13, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on MRUS as a result. In of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for MRUS turned negative on June 12, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MRUS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

MRUS broke above its upper Bollinger Band on May 23, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MRUS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.623) is normal, around the industry mean (16.366). P/E Ratio (0.000) is within average values for comparable stocks, (58.189). MRUS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.309). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (64.935) is also within normal values, averaging (252.247).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
MRUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

MRUS is expected to report earnings to fall 18.57% to -113 cents per share on July 31

Merus NV MRUS Stock Earnings Reports
Q2'25
Est.
$-1.14
Q1'25
Missed
by $0.29
Q4'24
Beat
by $0.48
Q3'24
Missed
by $0.60
Q2'24
Missed
by $0.05
The last earnings report on May 07 showed earnings per share of -139 cents, missing the estimate of -111 cents. With 113.82K shares outstanding, the current market capitalization sits at 3.95B.
A.I. Advisor
published General Information

General Information

a developer of therapeutics for cancer treatment

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
Uppsalalaan 17
Phone
+31 302538800
Employees
229
Web
https://www.merus.nl
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LRSRX13.150.06
+0.46%
Lord Abbett Small Cap Value R3
GVIRX17.510.07
+0.41%
Goldman Sachs US Eq Div and Premium Inv
VGSLX125.450.39
+0.31%
Vanguard Real Estate Index Admiral
DBMCX23.010.04
+0.17%
BNY Mellon Sm/Md Cp Gr C
SCETX7.18N/A
N/A
Virtus Ceredex Small-Cap Value Eq I

MRUS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MRUS has been loosely correlated with VIGL. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if MRUS jumps, then VIGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRUS
1D Price
Change %
MRUS100%
-0.47%
VIGL - MRUS
49%
Loosely correlated
N/A
CGON - MRUS
47%
Loosely correlated
-0.46%
RVMD - MRUS
46%
Loosely correlated
-1.52%
IDYA - MRUS
45%
Loosely correlated
-4.13%
ACLX - MRUS
44%
Loosely correlated
+0.90%
More